Global Hospital-acquired Infection Diagnostics Market Insights and Forecast to 2031

Report ID: 1564659 | Published Date: Nov 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Instrument and Reagents
        1.2.3 Consumables
    1.3 Market by Application
        1.3.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Ambulatory Surgery Centers (ASC)
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hospital-acquired Infection Diagnostics Market Perspective (2017-2028)
    2.2 Hospital-acquired Infection Diagnostics Growth Trends by Region
        2.2.1 Hospital-acquired Infection Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hospital-acquired Infection Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Hospital-acquired Infection Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Hospital-acquired Infection Diagnostics Market Dynamics
        2.3.1 Hospital-acquired Infection Diagnostics Industry Trends
        2.3.2 Hospital-acquired Infection Diagnostics Market Drivers
        2.3.3 Hospital-acquired Infection Diagnostics Market Challenges
        2.3.4 Hospital-acquired Infection Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue
        3.1.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hospital-acquired Infection Diagnostics Revenue
    3.4 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio
        3.4.1 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Infection Diagnostics Revenue in 2021
    3.5 Hospital-acquired Infection Diagnostics Key Players Head office and Area Served
    3.6 Key Players Hospital-acquired Infection Diagnostics Product Solution and Service
    3.7 Date of Enter into Hospital-acquired Infection Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired Infection Diagnostics Breakdown Data by Type
    4.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2023-2028)
5 Hospital-acquired Infection Diagnostics Breakdown Data by Application
    5.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hospital-acquired Infection Diagnostics Market Size (2017-2028)
    6.2 North America Hospital-acquired Infection Diagnostics Market Size by Type
        6.2.1 North America Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Hospital-acquired Infection Diagnostics Market Share by Type (2017-2028)
    6.3 North America Hospital-acquired Infection Diagnostics Market Size by Application
        6.3.1 North America Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Hospital-acquired Infection Diagnostics Market Share by Application (2017-2028)
    6.4 North America Hospital-acquired Infection Diagnostics Market Size by Country
        6.4.1 North America Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Hospital-acquired Infection Diagnostics Market Size (2017-2028)
    7.2 Europe Hospital-acquired Infection Diagnostics Market Size by Type
        7.2.1 Europe Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Hospital-acquired Infection Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Application
        7.3.1 Europe Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Hospital-acquired Infection Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Hospital-acquired Infection Diagnostics Market Size by Country
        7.4.1 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Hospital-acquired Infection Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Hospital-acquired Infection Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Hospital-acquired Infection Diagnostics Market Size (2017-2028)
    9.2 Latin America Hospital-acquired Infection Diagnostics Market Size by Type
        9.2.1 Latin America Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Hospital-acquired Infection Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Hospital-acquired Infection Diagnostics Market Size by Application
        9.3.1 Latin America Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Hospital-acquired Infection Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Hospital-acquired Infection Diagnostics Market Size by Country
        9.4.1 Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Introduction
        11.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Advan DX
        11.2.1 Advan DX Company Details
        11.2.2 Advan DX Business Overview
        11.2.3 Advan DX Hospital-acquired Infection Diagnostics Introduction
        11.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.2.5 Advan DX Recent Developments
    11.3 Abbott
        11.3.1 Abbott Company Details
        11.3.2 Abbott Business Overview
        11.3.3 Abbott Hospital-acquired Infection Diagnostics Introduction
        11.3.4 Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.3.5 Abbott Recent Developments
    11.4 Astrazeneca PLC
        11.4.1 Astrazeneca PLC Company Details
        11.4.2 Astrazeneca PLC Business Overview
        11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Introduction
        11.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.4.5 Astrazeneca PLC Recent Developments
    11.5 Bayer Schering Pharma LLC
        11.5.1 Bayer Schering Pharma LLC Company Details
        11.5.2 Bayer Schering Pharma LLC Business Overview
        11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Introduction
        11.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.5.5 Bayer Schering Pharma LLC Recent Developments
    11.6 Becton Dickinson And Company
        11.6.1 Becton Dickinson And Company Company Details
        11.6.2 Becton Dickinson And Company Business Overview
        11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Introduction
        11.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.6.5 Becton Dickinson And Company Recent Developments
    11.7 Cepheid Inc.
        11.7.1 Cepheid Inc. Company Details
        11.7.2 Cepheid Inc. Business Overview
        11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Introduction
        11.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.7.5 Cepheid Inc. Recent Developments
    11.8 Roche AG
        11.8.1 Roche AG Company Details
        11.8.2 Roche AG Business Overview
        11.8.3 Roche AG Hospital-acquired Infection Diagnostics Introduction
        11.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.8.5 Roche AG Recent Developments
    11.9 Daiichi Sankyo
        11.9.1 Daiichi Sankyo Company Details
        11.9.2 Daiichi Sankyo Business Overview
        11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Introduction
        11.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.9.5 Daiichi Sankyo Recent Developments
    11.10 Hologic, Inc.
        11.10.1 Hologic, Inc. Company Details
        11.10.2 Hologic, Inc. Business Overview
        11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Introduction
        11.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
        11.10.5 Hologic, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Instrument and Reagents
    Table 3. Key Players of Consumables
    Table 4. Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Hospital-acquired Infection Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hospital-acquired Infection Diagnostics Market Share by Region (2017-2022)
    Table 8. Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hospital-acquired Infection Diagnostics Market Share by Region (2023-2028)
    Table 10. Hospital-acquired Infection Diagnostics Market Trends
    Table 11. Hospital-acquired Infection Diagnostics Market Drivers
    Table 12. Hospital-acquired Infection Diagnostics Market Challenges
    Table 13. Hospital-acquired Infection Diagnostics Market Restraints
    Table 14. Global Hospital-acquired Infection Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hospital-acquired Infection Diagnostics Revenue Share by Players (2017-2022)
    Table 16. Global Top Hospital-acquired Infection Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2021)
    Table 17. Ranking of Global Top Hospital-acquired Infection Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hospital-acquired Infection Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hospital-acquired Infection Diagnostics Product Solution and Service
    Table 21. Date of Enter into Hospital-acquired Infection Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Type (2017-2022)
    Table 25. Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Type (2023-2028)
    Table 27. Global Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hospital-acquired Infection Diagnostics Revenue Share by Application (2017-2022)
    Table 29. Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hospital-acquired Infection Diagnostics Revenue Share by Application (2023-2028)
    Table 31. North America Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Abbott Laboratories Company Details
    Table 62. Abbott Laboratories Business Overview
    Table 63. Abbott Laboratories Hospital-acquired Infection Diagnostics Product
    Table 64. Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 65. Abbott Laboratories Recent Developments
    Table 66. Advan DX Company Details
    Table 67. Advan DX Business Overview
    Table 68. Advan DX Hospital-acquired Infection Diagnostics Product
    Table 69. Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 70. Advan DX Recent Developments
    Table 71. Abbott Company Details
    Table 72. Abbott Business Overview
    Table 73. Abbott Hospital-acquired Infection Diagnostics Product
    Table 74. Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 75. Abbott Recent Developments
    Table 76. Astrazeneca PLC Company Details
    Table 77. Astrazeneca PLC Business Overview
    Table 78. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product
    Table 79. Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 80. Astrazeneca PLC Recent Developments
    Table 81. Bayer Schering Pharma LLC Company Details
    Table 82. Bayer Schering Pharma LLC Business Overview
    Table 83. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product
    Table 84. Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 85. Bayer Schering Pharma LLC Recent Developments
    Table 86. Becton Dickinson And Company Company Details
    Table 87. Becton Dickinson And Company Business Overview
    Table 88. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product
    Table 89. Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 90. Becton Dickinson And Company Recent Developments
    Table 91. Cepheid Inc. Company Details
    Table 92. Cepheid Inc. Business Overview
    Table 93. Cepheid Inc. Hospital-acquired Infection Diagnostics Product
    Table 94. Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 95. Cepheid Inc. Recent Developments
    Table 96. Roche AG Company Details
    Table 97. Roche AG Business Overview
    Table 98. Roche AG Hospital-acquired Infection Diagnostics Product
    Table 99. Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 100. Roche AG Recent Developments
    Table 101. Daiichi Sankyo Company Details
    Table 102. Daiichi Sankyo Business Overview
    Table 103. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product
    Table 104. Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 105. Daiichi Sankyo Recent Developments
    Table 106. Hologic, Inc. Company Details
    Table 107. Hologic, Inc. Business Overview
    Table 108. Hologic, Inc. Hospital-acquired Infection Diagnostics Product
    Table 109. Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022) & (US$ Million)
    Table 110. Hologic, Inc. Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hospital-acquired Infection Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Instrument and Reagents Features
    Figure 3. Consumables Features
    Figure 4. Global Hospital-acquired Infection Diagnostics Market Share by Application: 2021 VS 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Ambulatory Surgery Centers (ASC) Case Studies
    Figure 8. Others Case Studies
    Figure 9. Hospital-acquired Infection Diagnostics Report Years Considered
    Figure 10. Global Hospital-acquired Infection Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Hospital-acquired Infection Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Hospital-acquired Infection Diagnostics Market Share by Region: 2021 VS 2028
    Figure 13. Global Hospital-acquired Infection Diagnostics Market Share by Players in 2021
    Figure 14. Global Top Hospital-acquired Infection Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Hospital-acquired Infection Diagnostics Revenue in 2021
    Figure 16. North America Hospital-acquired Infection Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Hospital-acquired Infection Diagnostics Market Size Share by Country (2017-2028)
    Figure 20. United States Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Hospital-acquired Infection Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Hospital-acquired Infection Diagnostics Market Size Share by Country (2017-2028)
    Figure 26. Germany Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Hospital-acquired Infection Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Share by Region (2017-2028)
    Figure 36. China Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Hospital-acquired Infection Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Hospital-acquired Infection Diagnostics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Hospital-acquired Infection Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Abbott Laboratories Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 56. Advan DX Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 57. Abbott Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 58. Astrazeneca PLC Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 59. Bayer Schering Pharma LLC Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 60. Becton Dickinson And Company Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 61. Cepheid Inc. Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 62. Roche AG Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 63. Daiichi Sankyo Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 64. Hologic, Inc. Revenue Growth Rate in Hospital-acquired Infection Diagnostics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Frequently Asked Questions
Hospital-acquired Infection Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hospital-acquired Infection Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hospital-acquired Infection Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Orthopedic Screws

Orthopedic Screws market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More